Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Evome Medical Technologies Inc V.EVMT

Alternate Symbol(s):  LNDZF

Evome Medical Technologies Inc. is an international medical device company, which is focused on human performance and rehabilitative solutions. The Company’s products include Biodex Rehab product, Damar Plastics product, Mio-Guard product, Simbex services, and SDP product. Its Biodex Rehab products include Isokinetic Systems, Gait Trainer, Body-Weight Supported Training, Cycles and Ergometers, and Squat-Assist Trainer. Its Mio-Guard products include bags, cases and kits, braces, and supports, diagnostics and instruments, furniture, and equipment, padding and splinting, personal protection, sanitizers and disinfectants, and tapes and wraps. Its applications include fall risk screening and conditioning, patient-driven payment model (PDPM), wellness, sports medicine solutions, neurological involvement, safe patient handling and mobility, and senior living and rehabilitation. It offers concussion, fall screening and balance assessment and training programs.


TSXV:EVMT - Post by User

Comment by Neptune3on Jan 25, 2016 12:59pm
151 Views
Post# 24490909

RE:RE:Financing, Share Consolidation and 10year-expiring options

RE:RE:Financing, Share Consolidation and 10year-expiring optionsI own the stock and will hold for future growth but not buy anymore. The roll back if necessary should be 1 for 4 at the very most and this rediculous huge options grant shows only managements greed in that they have put themselves way ahead of shareholders. Typical of D & G. This is why I feel that many are getting out. That said, eventually the price will follow the cash and earnings as they grow but when management thinks of themselves first before shareholders it will only hurt the company meaning share price. This will be an overhang on the stock as management cannot be trusted to act in the best interests of the sharholders first.    N3 
Bullboard Posts